Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Charny, Park"'
Autor:
Kyubin Lee, Daejin Hyung, Soo Young Cho, Namhee Yu, Sewha Hong, Jihyun Kim, Sunshin Kim, Ji-Youn Han, Charny Park
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 21, Iss , Pp 1978-1988 (2023)
Alternative splicing (AS) events modulate certain pathways and phenotypic plasticity in cancer. Although previous studies have computationally analyzed splicing events, it is still a challenge to uncover biological functions induced by reliable AS ev
Externí odkaz:
https://doaj.org/article/7988cf259f9e41028a2b65a58e3b840b
Autor:
Namhee Yu, Mihwa Hwang, Youngjoo Lee, Bo Ram Song, Eun Hye Kang, Hanna Sim, Beung-Chul Ahn, Kum Hui Hwang, Jihyun Kim, Sehwa Hong, Sunshin Kim, Charny Park, Ji-Youn Han
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-16 (2023)
Abstract Background A pharmacogenomic platform using patient-derived cells (PDCs) was established to identify the underlying resistance mechanisms and tailored treatment for patients with advanced or refractory lung cancer. Methods Drug sensitivity s
Externí odkaz:
https://doaj.org/article/e32f18ba5a954e30a49113074dfb0ffc
Autor:
Beung-Chul Ahn1, Charny Park2, Moon Soo Kim3, Jong Mog Lee3, Jin Ho Choi3, Hyae Young Kim4, Geon Kook Lee5, Namhee Yu2, Youngjoo Lee1, Ji-Youn Han1 jymama@ncc.re.kr
Publikováno v:
Cancer Research & Treatment. Jan2024, Vol. 56 Issue 1, p70-80. 11p.
Publikováno v:
Genomics, Proteomics & Bioinformatics, Vol 20, Iss 3, Pp 466-482 (2022)
Alternative splicing (AS) regulates biological processes governing phenotypes and diseases. Differential AS (DAS) gene test methods have been developed to investigate important exonic expression from high-throughput datasets. However, the DAS events
Externí odkaz:
https://doaj.org/article/f163f85958a64d66aca9c9e8777edd44
Autor:
Jihyun Kim, Charny Park, Kwang H. Kim, Eun Hye Kim, Hyunki Kim, Jong Kyu Woo, Je Kyung Seong, Ki Taek Nam, Yong Chan Lee, Soo Young Cho
Publikováno v:
npj Precision Oncology, Vol 6, Iss 1, Pp 1-11 (2022)
Abstract Single-cell transcriptomic profiles analysis has proposed new insights for understanding the behavior of human gastric cancer (GC). GC offers a unique model of intratumoral heterogeneity. However, the specific classes of cells involved in ca
Externí odkaz:
https://doaj.org/article/ea891fb371f24a39ad9957f7aa51ba58
Autor:
Daejin Hyung, Min-Jeong Baek, Jongkeun Lee, Juyeon Cho, Hyoun Sook Kim, Charny Park, Soo Young Cho
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 19, Iss , Pp 4759-4769 (2021)
Researchers have gained new therapeutic insights using multi-omics platform approaches to study DNA, RNA, and proteins of comprehensively characterized human cancer cell lines. To improve our understanding of the molecular features associated with on
Externí odkaz:
https://doaj.org/article/e6ec5a73816843ed81181b66dd6debfb
Autor:
Soo Young Cho, Heeyoun Hwang, Yun-Hee Kim, Byong Chul Yoo, Nayoung Han, Sun-Young Kong, Min-Jeong Baek, Kyung-Hee Kim, Mi Rim Lee, Jae Gwang Park, Sung-Sik Han, Woo Jin Lee, Charny Park, Jong Bae Park, Jin Young Kim, Sang-Jae Park, Sang Myung Woo
Publikováno v:
Gastroenterology. 164:1293-1309
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-8 (2019)
Abstract Gastric cancer (GC) is a heterogeneous disease, so molecular classification is important for selecting the most appropriate treatment strategies for GC patients. To be applicable in the clinic, there is an urgent need for a platform that wil
Externí odkaz:
https://doaj.org/article/d505ce14a42e4cabbaf7849682bbed00
Autor:
Jihyun Kim, June Hyuk Kim, Hyun Guy Kang, Seog Yun Park, Jung Yeon Yu, Eun Young Lee, Sung Eun Oh, Young Ho Kim, Tak Yun, Charny Park, Soo Young Cho, Hye Jin You
Publikováno v:
BMC Medical Genetics, Vol 19, Iss S1, Pp 1-11 (2018)
Abstract Background Several studies have investigated the molecular drivers and therapeutic targets in adult soft tissue sarcomas. However, such studies are limited by the genomic heterogeneity and rarity of sarcomas, particularly in those with compl
Externí odkaz:
https://doaj.org/article/508c161592b44075a29edb5202600378
Autor:
Beung Chul AHN, Charny Park, Sang-Jin Lee, Sehwa Hong, Ji-Eun Hwang, KyoungSuk Kwon, Kyung-Hee Kim, Hyae Young Kim, Geon Kook Lee, Youngjoo Lee, Ji-Youn Han
Purpose To investigate whether cyclophosphamide (C) and adriamycin (A) induction therapy (IT) prior to nivolumab could enhance the efficacy of nivolumab in previously treated patients with non-squamous (NSQ) non–small-cell lung cancer (NSCLC) with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::022e5cb6c9e01db462f9aa8a1539152c
https://doi.org/10.21203/rs.3.rs-2904735/v1
https://doi.org/10.21203/rs.3.rs-2904735/v1